Page
%P
-
Article
Cognitive improvement during Tolcapone treatment in Parkinson's disease
The aim of this study was to evaluate the effects of Tolcapone, a reversible, selective inhibitor of catechol-O-methyltransferase, on the cognitive functions of eight patients with advanced Parkinson's disease...
-
Article
Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain